Abstract
Purpose: Mitogen-activates protein kinase (MAPK) inhibitors, particularly MEK inhibitors, have shifted the treatment paradigm for metastatic BRAF-muta......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
